Translational research offers individually tailored treatments for cancer patients.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The cancer journal from Scientific American

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10696731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.

  1999cited by this paper
• Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

  1999cited by this paper
• Towards prediction and modulation of treatment response.

  1999cited by this paper
• Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

  1999cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

  1999cited by this paper
• Human cell membrane oxidative damage induced by single and fractionated doses of ionizing radiation: a fluorescence spectroscopy study.

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells

  1998cited by this paper
• Radiation-induced apoptosis--the ceramide-SAPK signaling pathway and clinical aspects.

  1998cited by this paper
• Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.

  1998cited by this paper
• The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis.

  1998cited by this paper
• Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.

  1998cited by this paper
• Implications of radiation induced apoptosis on calculated radial cell inactivation for a linear 192Ir source.

  1997cited by this paper
• Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.

  1997cited by this paper
• Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

  1997cited by this paper
• The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.

  1997cited by this paper
• Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial.

  1997cited by this paper
• Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.

  1997cited by this paper
• A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma.

  1997cited by this paper
• CDK-independent activation of estrogen receptor by cyclin D1.

  1997cited by this paper
• Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine.

  1997cited by this paper
• Detection of radiation-induced chromosome aberrations using fluorescence in situ hybridization in drug-induced premature chromosome condensations of tumour cell lines with different radiosensitivities.

  1997cited by this paper
• TAK1 Mediates the Ceramide Signaling to Stress-activated Protein Kinase/c-Jun N-terminal Kinase*

  1997cited by this paper
• Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.

  1997cited by this paper
• Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.

  1997cited by this paper
• Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

  1996cited by this paper
• The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat.

  1996cited by this paper
• A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA

  1996cited by this paper
• The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation.

  1996cited by this paper
• Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer.

  1996cited by this paper
• 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.

  1996cited by this paper
• Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

  1996cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Radiation-induced apoptosis: relevance to radiotherapy.

  1995cited by this paper
• Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells (*)

  1995cited by this paper
• Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis

  1994cited by this paper
• Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors.

  1994cited by this paper
• Apoptosis induced at different dose rates: implication for the shoulder region of cell survival curves.

  1994cited by this paper
• Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo.

  1994cited by this paper
• The sphingomyelin cycle and the second messenger function of ceramide.

  1994cited by this paper
• Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

  1994cited by this paper
• Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation.

  1994cited by this paper
• Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction.

  1994cited by this paper
• Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.

  1992cited by this paper
• The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer.

  1992cited by this paper
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.

  1992cited by this paper
• The effect of treatment duration in the local control of cervix cancer.

  1992cited by this paper
• Sphingomyelin and derivatives as cellular signals.

  1991cited by this paper
• Cisplatin and radiation: interaction probabilities and therapeutic possibilities.

  1990cited by this paper
• Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.

  1990cited by this paper
• Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx.

  1988cited by this paper
• Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.

  1988cited by this paper
• Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion

  1987cited by this paper
• Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation.

  1986cited by this paper
• A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.

  1985cited by this paper

• Breast Cancer

  2019cites this paper
• DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine

  2016cites this paper
• Individualizing cancer therapy

  2010cites this paper
• Great 21st Century Debates About The Usefulness Of Research: Can They Help Rural Research?

  2008cites this paper
• Serum soluble interleukin 2 receptor α in human cancer of adults and children: a review

  2008cites this paper
• The future of surgical research: the role of the American College of Surgeons Oncology Group.

  2005cites this paper
• The choice of systemic adjuvant therapy in receptor-positive early breast cancer.

  2005cites this paper
• Models for Biomarkers and Minimal Residual Tumor

  2004cites this paper
• Prognostic and Predictive Molecular Markers: Are We Ready for their Clinical Use? The Opinion of a Clinical Biochemist

  2003cites this paper
• Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.

  2003cites this paper
• Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.

  2003cites this paper
• Large hepatic ablation with bipolar saline-enhanced radiofrequency: an experimental study in in vivo porcine liver with a novel approach.

  2003cites this paper
• Clinical Perspectives in Head and Neck Cancer

  2003cites this paper
• The Role of Platinum Complexes in Combined Modality Therapy

  2003cites this paper
• The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer.

  2002cites this paper
• Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.

  2002cites this paper
• From translational research to improved local control and survival: the Gilbert Fletcher Award Lecture, Lugano, March 2000.

  2001cites this paper
• Basic Science and Translational Research: Call for Papers

  2001cites this paper
• Hepatocellular carcinoma: surgical treatment options.

  2001cites this paper
• Molecular-targeted anticancer therapy: challenges related to study design and choice of proper endpoints.

  2000cites this paper